The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).
 
Mohammad O. Atiq
Travel, Accommodations, Expenses - Agios; Alnylam (I); Astellas Pharma; AstraZeneca (I); Daiichi Sankyo Inc. (I); Foundation Medicine (I); Genentech (I); Gilead Sciences (I); Incyte; Jazz Pharmaceuticals; Pfizer; Pfizer (I)
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst); ImmunityBio (Inst); NextCure (Inst)
 
Fatima Karzai
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
Julius Strauss
Research Funding - Bavarian Nordic (Inst); EMD Serono (Inst); ImmunityBio (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on NIH pending patent (Inst)
 
Houssein Abdul Sater
No Relationships to Disclose
 
Jason Redman
No Relationships to Disclose
 
Charalampos S. Floudas
No Relationships to Disclose
 
James W. Hodge
No Relationships to Disclose
 
Sofia Gameiro
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst); EMD Serono/Merck (Inst); ImmunityBio (Inst); Incyte (Inst); NextCure (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
William L. Dahut
No Relationships to Disclose
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer